Cash-pay IV hydration and infusion clinics are trading at 3x–5.5x EBITDA in the lower middle market. Here is how buyers determine value — and what sellers can do to maximize their exit price.
Find IV Therapy Clinic Businesses For SaleIV therapy clinics are typically valued on a multiple of Seller's Discretionary Earnings (SDE) for owner-operated single locations under $1M in EBITDA, or on an EBITDA basis for multi-location platforms and those targeting institutional buyers. Because these are cash-pay medical businesses with no insurance reimbursement exposure, buyers place a premium on recurring membership revenue, transferable medical director agreements, and documented clinical protocols. Valuations in the lower middle market currently range from 3x to 5.5x EBITDA, with the widest spread in the industry driven by regulatory risk, owner dependency, and the maturity of the membership program.
3×
Low EBITDA Multiple
4×
Mid EBITDA Multiple
5.5×
High EBITDA Multiple
A 3x multiple typically applies to single-location clinics where the owner serves as medical director or primary nurse, revenue is largely walk-in based, and clinical documentation is informal. A 4x mid-range multiple reflects a clinic with a transferable medical director agreement, 150–250 active members, and two or more years of clean financials. The 5.5x ceiling applies to multi-location operators or platforms with 300+ active members, diversified service menus including NAD+ and peptide therapies, proven management teams independent of the owner, and strong Google reputations with documented referral pipelines.
$1,800,000
Revenue
$540,000
EBITDA
4.2x
Multiple
$2,268,000
Price
Asset purchase at $2,268,000. Financed with SBA 7(a) loan covering $1,900,000 (84%), a $250,000 seller note at 6% over 5 years, and $118,000 buyer equity injection. Seller earnout of $150,000 tied to 12-month post-close membership retention above 85% of pre-close active member count. Medical director retains position under a new agreement executed at close.
EBITDA Multiple
The most common institutional valuation method for IV therapy clinics generating over $500K in annual EBITDA. A normalized EBITDA — adjusted for owner compensation, one-time expenses, and any above-market medical director fees — is multiplied by a factor between 3x and 5.5x depending on clinic quality, regulatory standing, and recurring revenue profile.
Best for: Multi-location clinics, PE-backed rollup targets, and businesses with $500K+ EBITDA and a management team in place
Seller's Discretionary Earnings (SDE) Multiple
For owner-operator IV therapy clinics where the founder works in the business as nurse, NP, or medical director, SDE adds back owner compensation and perks to net income to reflect total economic benefit to a buyer-operator. SDE multiples for IV clinics typically range from 2.5x to 4x depending on revenue size and transferability of key relationships.
Best for: Single-location owner-operated clinics under $1M revenue where the buyer plans to operate the business personally
Revenue Multiple
Occasionally used as a sanity check or for early-stage clinics with thin margins, revenue multiples for IV therapy businesses typically range from 0.8x to 1.5x annual revenue. This method is less reliable given the wide variance in operating costs between clinics, but can be useful when benchmarking against recent comparable transactions in the cash-pay wellness sector.
Best for: Valuation benchmarking, early-stage clinics with strong revenue but developing margins, or buyers comparing acquisition vs. de novo build costs
Active Membership Program with 200+ Members
A documented monthly membership program — offering discounted infusion packages or unlimited hydration visits — is the single most powerful value driver in IV therapy clinic M&A. Buyers pay premium multiples for predictable monthly recurring revenue (MRR). Clinics with 200+ active members and documented retention rates above 70% month-over-month are significantly more attractive than walk-in dependent businesses.
Transferable Medical Director Agreement
A written medical director agreement with a licensed physician who is willing to remain post-close — and whose agreement contains an assignability clause — dramatically reduces regulatory and operational risk for buyers. Clinics that have already separated the medical director role from the owner-operator and have a physician under contract with at least 12 months remaining command materially higher multiples.
Diversified Service Menu Including NAD+ and Weight Loss Protocols
Clinics offering high-margin add-on services beyond basic hydration — including NAD+ infusions, glutathione pushes, peptide injections, and GLP-1 or weight loss programs — generate significantly higher average revenue per visit. Buyers targeting rollup strategies specifically seek this diversification as it increases wallet share per client and protects against commoditization of standard vitamin drips.
Multi-Location Footprint or Proven Mobile Unit Model
Operating two or more clinic locations, or a mobile IV unit serving corporate clients, events, and concierge home visits, reduces single-location dependency risk. Multi-site operators also demonstrate management scalability, making them far more attractive to PE-backed rollup platforms and reducing the buyer's concern that revenue will evaporate if one location underperforms post-close.
Strong Online Reputation and Referral Partnerships
A 4.8+ star Google rating with 200+ reviews, combined with documented referral relationships with gyms, CrossFit affiliates, sports teams, concierge medicine practices, and corporate wellness programs, signals durable demand and local brand moat. These relationships are difficult for national franchises or new entrants to replicate quickly and are viewed as proprietary distribution channels by acquirers.
Owner Serves as Sole Medical Director with No Succession Plan
When the selling owner is also the clinic's medical director — and no replacement physician has been identified — buyers face immediate regulatory and operational exposure at close. In many states, the clinic cannot legally operate without a licensed physician overseeing protocols. This single issue is the most common reason IV therapy clinic deals collapse or receive heavy valuation discounts of 0.5x–1.5x EBITDA.
Walk-In Revenue Dominance with No Loyalty Program
A clinic where 80%+ of revenue comes from one-time or infrequent walk-in clients has no predictable baseline cash flow from which a buyer can service acquisition debt. Buyers using SBA financing must demonstrate cash flow stability to lenders, and a membership-light business creates significant lender hesitancy and downward multiple pressure.
Undocumented Clinical Protocols or Prior Regulatory Violations
Missing patient intake forms, undocumented IV infusion protocols, unresolved state health department citations, or prior board of nursing complaints are immediate red flags in due diligence. Healthcare-specific buyers and their attorneys will conduct a thorough compliance review, and any gaps can result in deal re-trades, escrow holdbacks, or outright termination of the purchase agreement.
Non-Compliant or Uncontracted Compounding Pharmacy Relationships
Many IV therapy clinics source compounded NAD+, glutathione, and high-dose vitamin formulations from compounding pharmacies. If these relationships are undocumented, with pharmacies lacking 503B FDA outsourcing facility registration, or based on informal arrangements not transferable to a new owner, buyers face both regulatory liability and supply chain risk that directly affects their ability to maintain the full service menu post-close.
Revenue Concentration in a Single Corporate Wellness Client
A corporate wellness contract representing more than 20–25% of total clinic revenue that is not contractually assigned to the buyer — or that may not renew post-ownership-change — represents significant concentration risk. Buyers will heavily discount or escrow against this exposure, and SBA lenders may reduce loan eligibility based on customer concentration thresholds.
Find IV Therapy Clinic Businesses For Sale
Signal-scored targets with seller motivation, multiples, and outreach — free to join.
Most IV therapy clinics in the lower middle market sell for 3x to 5.5x EBITDA. The exact multiple depends on whether your medical director agreement is transferable, how large and sticky your membership base is, your number of locations, and how clean your clinical documentation and financials are. A single-location walk-in clinic with an owner-operator medical director will trade near 3x. A multi-location clinic with 300+ active members, a contracted physician, and diversified services including NAD+ therapy can approach 5x to 5.5x.
Yes. IV therapy clinics are generally SBA 7(a) eligible as cash-flow-positive small businesses, provided the clinic has at least two years of operating history and documented profitability. Lenders will scrutinize the medical director structure, customer concentration, and state licensing compliance carefully. Buyers typically finance 75–90% of the purchase price through SBA 7(a) loans, with the remainder covered by a seller note or equity. Working with an SBA lender experienced in healthcare-adjacent transactions significantly improves approval speed and loan structure.
The most common value killers are owner-dependency as the sole medical director, a lack of a formalized membership program, undocumented clinical protocols, and non-assignable compounding pharmacy relationships. Clinics that cannot demonstrate a clean handoff — where the business continues operating without the founder — are consistently discounted by 20–40% or struggle to attract qualified buyers. Sellers should begin addressing these issues 12–18 months before going to market.
Buyers treat recurring membership revenue as the most valuable component of an IV therapy clinic's cash flow. A membership program with 200+ active members, documented month-over-month retention above 70%, and average monthly revenue per member of $100–$200 can add 0.5x to 1.0x to the EBITDA multiple versus a comparable clinic without memberships. Buyers will request at least 12 months of membership cohort data, churn rates, and average tenure to underwrite this value.
Yes, significantly. IV therapy clinics operate under a patchwork of state laws governing corporate practice of medicine, nurse and NP scope of practice for IV administration, and compounded pharmaceutical oversight. States with strict corporate practice of medicine rules may require specific ownership structures that complicate an asset purchase. Buyers will conduct jurisdiction-specific compliance due diligence, and clinics in states with recent enforcement actions or unclear regulatory guidance will face buyer caution and potential deal structure modifications to limit successor liability.
The average exit timeline for an IV therapy clinic is 12 to 18 months from the decision to sell through close. This includes 3–6 months of pre-sale preparation — building financials, formalizing protocols, and recruiting a replacement medical director if needed — followed by 3–6 months of active marketing and buyer qualification, and a 60–90 day due diligence and closing period. Sellers who begin preparation early and engage a healthcare-specialized M&A advisor or business broker typically achieve faster closings and better terms.
Nearly all IV therapy clinic transactions in the lower middle market are structured as asset purchases, not stock sales. In an asset sale, the buyer acquires the clinic's equipment, customer relationships, trade name, contracts, and goodwill without assuming the seller's historical liabilities. This is preferred by buyers because it limits exposure to prior malpractice claims, regulatory violations, and unknown liabilities. Sellers may prefer a stock sale for tax efficiency, but buyers will typically resist unless accompanied by significant representations, warranties insurance, or escrow holdbacks.
More IV Therapy Clinic Guides
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers